Why and how correct calcidiol deficiency in haemodialysis patients?;Pourquoi et comment corriger le déficit en calcidiol chez les patients hémodialysés ?

Nephrologie et Therapeutique

Volumn 5, Issue 6, 2009, Pages 542-549

  Maheut, Hervé ^a   Chevriot, Fabien ^a   Marty, Hélène ^a   Lavaud, Sylvie ^a   Kazes, Isabelle ^a   Chanard, Jacques ^a   Rieu, Philippe ^a  

^a HÔPITAL MAISON BLANCHE   (France)

Author keywords

Calcidiol; Dialysis; Ergocalciferol; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; ERGOCALCIFEROL; OXYGENASE; PARATHYROID HORMONE; PHOSPHATE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RECOMMENDED DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; AVITAMINOSIS; CALCIFEDIOL; ERGOCALCIFEROLS; HUMANS; RENAL DIALYSIS; VITAMINS;

EID: 71249094669     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2009.05.002     Document Type: Article

References (28)

1. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology inend-stage renal disease. Kidney Int 1993;44:1071-7.
2. Levin A., Bakris G.L., Molitch M., Smulders M., Tian J., Williams L.A., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71 (2007) 31-38
3. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
4. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25 (OH) D levels and extrarenal 1alpha-hydroxylase in the classical and non classical actions of 1α, 25-dihydroxyvitamin D. Semin Dialysis 20 (2007) 316-324
5. National Kidney Foundation. K/DOQI. Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Guideline 7. Prevention and treatment of vitamin D insufficiency and vitamin D deficiency in CKD patients. Am J Kidney Dis 2003;42 (Suppl. 3):S1-201.
6. Dusso A., Lopez - Hilker S., Rapp N., and Slatopolsky E. Extrarenal production of calcitriol in chronic renal failure. Kidney Int 34 (1988) 368-375
7. Ritter C.S., Armbrecht H.J., Slatopolsky E., and Brown A.J. 25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70 (2006) 654-659
8. London G.M., Guerin A.P., Verbeke F.H., Pannier B., Boutouyrie P., Marchais S.J., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin deficiency. J Am Soc Nephrol 18 (2007) 613-620
9. Wolf M., Shah A., Guttierez O., Ankers E., Monroy M., Tamez H., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72 (2007) 909-911
10. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
11. National Kidney Foundation. K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Guideline 8B. Vitamin D therapy in patients on dialysis (CKD stage 5). Am J Kidney Dis 2003;42 (Suppl. 3):S1-201.
12. Chevriot F. Dosage de la 25-hydroxyvitamine D par chimiluminescence : mise en place et bilan au CHU de Reims. Thèse de Pharmacie. Reims : université de Reims ; 2007.
13. Sadek T., Mazouz H., Bahloul H., Oprisiu R., El Esper N., El Esper I., et al. Sevelamer hydrochloride with or without alfacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients:an open-label, randomized study. Nephrol Dial Transplant 18 (2003) 582-589
14. Del Valle E., Negri A.L., Aguirre C., Fradinger E., and Zanchetta J.R. Prevalence of 25(OH) vitamin D insufficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 3 (2007) 315-321
15. Gonzalez E.A., Sachdeva A., Oliver D.A., and Martin K.J. Vitamin D insufficiency and deficiency in chronic kidney disease. Am J Nephrol 24 (2004) 503-510
16. Ishimura E., Nishizawa Y., Inaba M., et al. Serum levels of 1,25-dihydroxyvitamin D, 24, 25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55 (1999) 1019-1027
17. La Clair R.E., Hellman R., Karp S.L., Kraus M., Ofner S., Li Q., et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45 (2005) 1119-1122
18. Chonchol M., and Scragg R. Hydroxyvitamin D, insulin, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71 (2007) 134-139
19. Al-Aly Z., Qazi R.A., Gonzalez E.A., Zeringue A., and Martin K.J. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50 (2007) 59-68
20. Zisman AL, Hristova M, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 200;27:36-43.
21. Saab G., Young D.O., Gincherman Y., Giles K., Norwood K., and Coyne D.W. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105 (2007) [c 132-8]
22. Chandra P., Binongo J.N., Ziegler T.R., Schlanger L.E., Wang W., Someren J.T., et al. Cholecalciferol therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14 (2008) 10-17
23. Jean G., Terrat J.C., Vanel T., Hurot J.M., Lorriaux C., Mayor B., et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in Haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant (2008) [Advance access June 24]
24. Tokmak F., Quack I., Schieren G., Sellin L., Rattensperger D., Holland-Letz T., et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant (2008) [Advance access July 1]
25. Holick M.F., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93 (2008) 677-681
26. Armas L.A., HollisBW, and Heaney R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89 (2004) 5387-5391
27. 2) as a vitamin supplement. Am J Clin Nutr 84 (2006) 694-697
28. Jean G, Terrat JC, Vanel T, Hurot JM, Loriaux C, Mayor B, Chazot C. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25 dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferoltreatment. Nephron Clin Pract 2008;110:58-65.